Emergent BioSolutions Inc (NYSE: EBS) stock suffered a major decline of -14.2% on 2/18/25. The shares closed at $8.34. Moreover, unusually high trading volume at 187% of normal accompanied the decline. The stock has declined -16.6% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Emergent BioSolutions has a current Value Trend Rating of A (Highest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Emergent BioSolutions has a good Appreciation Score of 72 and a good Power Rating of 79, with the Highest Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment